首页
400-620-6333
抗体
选项
-
Catumaxomab (anti-CD3&EpCAM)
- 简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Mouse IgG2a & Rat IgG2b; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 大鼠(Rat), 小鼠(Mouse)
- 亚型: Mouse IgG2a & Rat IgG2b
- 宿主种属: Mouse; Rat
- 偶联: Unconjugated
CAS号 : 509077-98-9 -
Datopotamab deruxtecan (anti-TROP2)关联靶标: TACSTD2
- 简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-GGFG-DXd)
- 种属反应性: 人(Human), 大鼠(Rat), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: MC-GGFG-DXd
CAS号 : 2238831-60-0SMILES: [Datopotamab deruxtecan] -
Pinatuzumab vedotin (anti-CD22)关联靶标: CD22
- 简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAE)
- 种属反应性: 人(Human), 大鼠(Rat), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: MC-VC-PAB-MMAE
CAS号 : 1313706-14-7 -
Abbott patent anti-NGR (anti-NGR)关联靶标: RTN4R
- 简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1-REM-FEA; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 大鼠(Rat)
- 亚型: Human IgG1-REM-FEA
- 宿主种属: 人(Human)
- 偶联: Unconjugated
